Best Cardiologists and Heart Medicine Doctors in East Weymouth, MA

Gaurav Gulati, MD is a cardiologist in Advanced Heart Failure and Transplant Cardiology and an Assistant Professor of Medicine at Tufts University School of Medicine. He specializes in cardiomyopathies, heart failure, heart transplantation, ventricular assist devices (VAD) and cardiogenic shock. His research focus areas include hemodynamics, pulmonary hypertension, LVAD management and right heart failure. In 2019 he received the Gold Ribbon Abstract from the Association for Clinical and Translational Sciences Scientific Sessions. The same year he was awarded first place in the CardioVascular Center Research Symposium Poster Competition, Tufts Medical Center. He is a member of the American College of Cardiology, Heart Failure Society of America and The International Society for Heart and Lung Transplantation.

Dr. Kapur is a dual, board-certified Interventional Cardiologist and Advanced Heart Failure/Cardiac Transplant specialist. He is Director of the Acute Circulatory Support Program and Associate Director of the Cardiac Catheterization Laboratory at Tufts Medical Center. His clinical expertise focuses on invasive hemodynamics, mechanical circulatory support, and interventional therapies for patients with advanced heart failure. He serves on several national committees involved with the American Heart Association, the American College of Cardiology, the Heart Failure Society of America, and the Society for Cardiac Angiography and Interventions. As Director of the Interventional Research Laboratories at Tufts Medical , Dr. Kapur's translational research focuses on large animal models of acute and chronic heart failure, circulatory support device development, and cardioprotective mechanisms in the setting of acute myocardial infarction. His recent work has focused on the hypothesis that mechanically unloading the heart and delaying coronary reperfusion limits infarct size. This concept known as the 'mechanical conditioning hypothesis' has the potential to alter the paradigm of acute heart attack therapy and reduce the burden of ischemic heart failure. As Director of the Cardiac Biology Research Center within the Molecular Cardiology Research Institute at Tufts Medical Center, Dr. Kapur's basic science laboratory focuses on molecular mechanisms governing maladaptive cardiac remodeling in heart failure. His particular expertise involves signaling via the transforming growth factor beta (TGFb) system. Over the past 6 years, the laboratory has published several critical papers focused on a TGFb co-receptor known as endoglin and was the first to establish that reduced endoglin activity improves survival and limits maladaptive cardiac remodeling in heart failure. More recently, the laboratory has demonstrated that targeting endoglin using an antibody-mediated approach not only limits the development of cardiac fibrosis, but can reverse established cardiac fibrosis in preclinical models of heart failure. Dr. Kapur is the recipient of grant funding from the National Institutes of Health, American Heart Association, and several industry sponsors.

Michael S. Kiernan, MD, MS, MBA is the Medical Director of the Ventricular Assist Device (VAD) Program and an Assistant Professor at Tufts University School of Medicine. He specializes in cardiomyopathies, heart failure, cardiac transplantation and ventricular assist devices. His research focus areas include physiology of mechanical circulatory support and cardiorenal interactions in heart failure. He has received numerous awards including the Teaching Award from the Department of Medicine at Tufts Medical Center in 2010 and the Excellence in Medicine Award from the University of Connecticut School of Medicine in 2004. In 2009, Dr. Kiernan was the Chief Cardiology Fellow at Tufts Medical Center. He is a member of the International Society of Heart & Lung Transplantation, Heart Failure Society of America, American Heart Association and the American College of Cardiology.